Seltorexant Clinical Trials (2026): 14 Studies for Depressive Disorder, Major & Healthy

Where to Participate: All Seltorexant Trial Sites in the U.S. (45 sites across 18 states)

Every actively recruiting Seltorexanttrial site, sorted by state then city. Each row links to the trial detail page (eligibility, contacts, full study record). Sites no longer enrolling at the location level are excluded. ClinicalTrials.gov / AACT does not provide street-level addresses; the map link uses the facility's geocoded coordinates where available.

Seltorexant clinical trials at a glance: phase × recruitment status

Recruiting Seltorexant clinical trials (1)

Studies currently enrolling participants. Click any NCT ID to view the trial detail page (eligibility, sites, contacts).

Seltorexant clinical trials by indication

Terminated and withdrawn Seltorexant trials (2)

Studies that ended before completion. Reasons are filed in each trial's ClinicalTrials.gov entry.

• NCT04951609terminatedA Study of Seltorexant as Adjunctive Therapy to Antidepressants in Adolescents With Major Depressive Disorder Who Have an Inadequate Response to Selective Serotonin Reuptake Inhibitor (SSRI) and Psychotherapy
• NCT04532749terminatedA Study of Seltorexant as Adjunctive Therapy to Antidepressants in Adult and Elderly Participants With Major Depressive Disorder With Insomnia Symptoms Who Have Responded Inadequately to Antidepressant Therapy

All Seltorexant trials (14)

Sorted by most recent activity (completion → start → posted date). Each row links to the trial detail page on Hipa.ai.

Seltorexant clinical trials: frequently asked questions

How many Seltorexant clinical trials are there?

14 Seltorexant clinical trials are catalogued on Hipa.ai, sourced from the AACT mirror of ClinicalTrials.gov. 1 is actively recruiting participants. 11 are marked completed.

Are Seltorexant clinical trials recruiting in 2026?

Yes — 1 Seltorexant trial is actively recruiting in 2026, with 45 U.S. sites across 18 states. See the recruiting trials and the per-state site list further down this page.

What conditions is Seltorexant being studied for?

Seltorexant is being studied for Depressive Disorder, Major, Healthy, Abuse Potential, Alzheimer Disease, Healthy Non-dependent, Recreational Sedative Users and 1 more. The trials are grouped by indication on this page.

What phase is Seltorexant in?

Seltorexant clinical trials span 4 Phase 3, 1 Phase 2, 9 Phase 1. The phase × status matrix at the top of this page breaks down counts by phase and recruitment status.

Who sponsors Seltorexant clinical trials?

The lead sponsor across the most Seltorexant trials is Janssen Research & Development, LLC. Each trial row links to the full study detail page including sponsor information.

Sources and methodology

Trial inventory derived from the AACT mirror of ClinicalTrials.gov. Trials are filtered to those naming Seltorexantas an intervention. Phase, status, enrollment, sponsor, and dates are taken from the source `studies` table; primary indication is the first listed condition. Acronyms are extracted from each trial's brief title where present. PubMed links are populated for trials whose published primary outcomes have been indexed in our evidence cache.

Last refreshed June 12, 2026.